Skip to main content

TOFACITINIB CITRATE

NDC 50228-567 · ScieGen Pharmaceuticals, INC.

Generic nameTofacitinib citrate
Dosage formTABLET, FILM COATED, EXTENDED RELEASE
RouteORAL
Active ingredient(s)TOFACITINIB CITRATE
Strength11 mg/1
Pharmacologic classJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
Marketing categoryANDA

Packages

50228-567-10 — 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-567-10)

50228-567-30 — 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-567-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0069-1001 — tofacitinib, 0069-1002 — tofacitinib, 0069-1029 — tofacitinib, 0574-1811 — Tofacitinib Citrate, 27241-270 — Tofacitinib, 33342-541 — Tofacitinib, 33342-542 — Tofacitinib, 42571-268 — tofacitinib, 42571-377 — tofacitinib, 42799-970 — Tofacitinib, 51991-329 — Tofacitinib Citrate, 51991-963 — Tofacitinib Citrate, 59651-459 — TOFACITINIB, 59651-460 — TOFACITINIB, 59651-685 — TOFACITINIB, 60505-4858 — tofacitinib, 63539-012 — tofacitinib, 63539-016 — tofacitinib, 63539-029 — tofacitinib, 63539-501 — tofacitinib, +27 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.